News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Galenea Awarded $3 Million National Institutes of Health (NIH) Grant to Develop Translational EEG Biomarkers for Schizophrenia


9/6/2012 10:20:02 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Researchers at Galenea Corp., and collaborator Kevin Spencer of the VA Boston Healthcare System and Harvard Medical School, have been awarded a 5-year, $3M grant from the National Institute of Mental Health (NIMH). The grant will fund the development of new biomarkers based on brain wave oscillations in animal models of psychosis and in human schizophrenia patients. The program will incorporate Galenea’s sophisticated in vivo electroencephalography (EEG) technology alongside Dr. Spencer’s innovations in clinical EEG measures.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES